eHealth in Treatment of Gestational Diabetes (eMOMGDM) (eMOMGDM)
eHealth in Treatment of Gestational Diabetes - eMOM GDM -Study (Phase 2)
Sponsor: Aalto University
A NA clinical study on Gestational Diabetes and Mobile Application, this trial is ongoing. The trial is conducted by Aalto University and has accumulated 12 data snapshots since 2021. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
12 versions recorded-
Jan 2025 — Present [monthly]
Active Not Recruiting NA
-
Sep 2024 — Jan 2025 [monthly]
Active Not Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting NA
-
Dec 2023 — Jul 2024 [monthly]
Active Not Recruiting NA
-
Sep 2023 — Dec 2023 [monthly]
Active Not Recruiting NA
▶ Show 7 earlier versions
-
Apr 2023 — Sep 2023 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Nov 2022 — Apr 2023 [monthly]
Recruiting NA
-
Sep 2022 — Nov 2022 [monthly]
Recruiting NA
-
Jun 2022 — Sep 2022 [monthly]
Recruiting NA
-
Sep 2021 — Jun 2022 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Apr 2021 — Sep 2021 [monthly]
Not Yet Recruiting NA
-
Feb 2021 — Apr 2021 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Aalto University
- Business Finland
- Elisa Oyj
- Finnish Institute for Health and Welfare
- Fujitsu
- Helsinki University Central Hospital
- Tampere University
- UKK Institute
- University of Helsinki
For direct contact, visit the study record on ClinicalTrials.gov .